| Methods |
In the treatment of major depressive disorder, in addition to the remission of symptoms, improvement in functionality and subjective quality of life of the patients is desirable. In this study, we aimed to evaluate and compare the changes in quality of life measures in citalopram‐ versus escitalopram‐treated major depressive disorder patients, and to compare the scores of the patients who achieved remission at the end of treatment with standard scores of the Turkish population. |
| Participants |
74 outpatients with major depressive disorder |
| Interventions |
Citalopram was started at a dose of 20 mg/day, and escitalopram was started at a dose of 10 mg/day. At the end of the 6th week, the mean dose for the citalopram treated patients was 24.6 mg/day and for the escitalopram treated patients it was 11.8 mg/day. |
| Outcomes |
Treatment response was accepted as a 50% decrease in the index assessment and remission was accepted as HAM‐D<=7 |
| Notes |
|
